GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

The partnership between the pharmaceutical giant and the university aims to create a vaccine or vaccines which target cells ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...

A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...

A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...